Resources company focused of acquisition and development of oil and gas properties ME Resource Corp. has submitted an initial listing statement with the Canadian Securities Exchange (CSE) in coordination with its reverse take-over deal with Albert Labs.
Albert Labs is a laboratory based psychedelic company using real world evidence studies to enhance patient care and faster access to psychedelic therapy. The company is based in the UK and operates across Europe.
This listing statement submission will start a consulting phase by CSE with Albert Labs. Following this, listing of the company’s shares on CSE will only be granted after Albert Labs meet all requirements and conditions of CSE.
Through its chief operating officer, Chand Jagpal, Albert Labs is looking forward to this listing approval as it will mark a major achievement for the company becoming a public traded company which means it will have an expanded capital base.
“The much anticipated submission of the listing statement represents a significant milestone for Albert Labs. We’re excited to move towards our goal of becoming a public company to attract growth capital and enable Albert Labs to continue towards its goal of being a worldwide leader and provide accelerated access to psychedelics medicines and therapy,” said Jagpal.